Literature DB >> 14300263

A MORPHOLOGICAL STUDY OF THE RENAL LESION IN ANGIOKERATOMA CORPORIS DIFFUSUM UNIVERSALE (FABRY'S DISEASE).

W F MCNARY, L M LOWENSTEIN.   

Abstract

Keywords:  ANGIOKERATOMA; BIOPSY; GENETICS, HUMAN; KIDNEY DISEASES; MICROSCOPY, ELECTRON; PATHOLOGY

Mesh：

Year:  1965        PMID： 14300263     DOI： 10.1016/s0022-5347(17)63848-5

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  7 in total

1.  [Electron microscopic observations in internal organs in morbus Fabry (author's transl)].

Authors:  J Roth; H Roth
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-05-05

2.  Electron Microscopy of Nephropathia Epidemica. Glomerular changes.

Authors:  Y Collan; J Lähdevirta; E J Jokinen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-02-10

3.  Ultrastructure of foam cell nephropathy.

Authors:  H Oliva; L Hernando; V Navarro; C Jiménez Diaz
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1967

4.  [Analytical study of Fabry's disease (author's transl)].

Authors:  J Roth; E Schulze; G Raabe; G Waldmann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

5.  Clinical and electron microscopic studies of a case of glycolipid lipoidosis (Fabry's disease).

Authors:  A I Rae; J C Lee; J Hopper
Journal:  J Clin Pathol       Date:  1967-01       Impact factor: 3.411

6.  Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy.

Authors:  P Vylet'al; H Hůlková; M Zivná; L Berná; P Novák; M Elleder; S Kmoch
Journal:  J Inherit Metab Dis       Date:  2008-07-27       Impact factor: 4.982

7.  Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy.

Authors:  Woo-Shik Kim; Hyun Soo Kim; Jinho Shin; Jong Chun Park; Han-Wook Yoo; Toshihiro Takenaka; Chuwa Tei
Journal:  J Korean Med Sci       Date:  2019-02-15       Impact factor: 2.153
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.